BiomX (PHGE) News Today → The A.I. story nobody is telling you (Read ASAP) (From TradeSmith) (Ad) Free PHGE Stock Alerts $0.34 -0.01 (-2.87%) (As of 04/24/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesSEC FilingsStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesSEC Filings All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineBiomX to Present Data from Phase 1b/2a Study of BX004 for the Treatment of Cystic Fibrosis Patients with Chronic Pulmonary Infections at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024)globenewswire.com - April 23 at 8:00 AMBiomX (NYSEMKT:PHGE) Given "Buy" Rating at HC Wainwrightamericanbankingnews.com - April 23 at 4:28 AMBiomX expands board with new director and audit chairinvesting.com - April 19 at 8:36 PMBiomX Announces the Appointment of Susan Blum to its Board of Directorsglobenewswire.com - April 18 at 8:00 AMBiomX receives going concern note from auditorsuk.investing.com - April 6 at 1:40 AMBiomX Announces Compliance with NYSE Guidelines on Audit Opinion Disclosureglobenewswire.com - April 4 at 7:49 AMU.S. Futures Dip in Pre-Market, May WTI and June Brent Crude Prices Edge Highermsn.com - April 3 at 10:25 AMBiomX Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updateglobenewswire.com - April 3 at 6:30 AMBiomX to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast on April 3rd, 2024globenewswire.com - March 27 at 6:30 AMBiomX Announces Closing of the Acquisition of Adaptive Phage Therapeutics and Concurrent $50 Million Financingglobenewswire.com - March 18 at 6:30 AMBiomX Buy Rating Justified by Merger Synergy, Enhanced Financial Stability, and Promising Clinical Trialsmarkets.businessinsider.com - March 7 at 12:16 PMBiomX Acquisition and Clinical Trial Successes Prompt Buy Rating by Analyst Michael Higginsmarkets.businessinsider.com - March 7 at 12:16 PMShareholder Alert: Ademi LLP investigates the transaction between BiomX Inc. and Adaptive Phage Therapeuticsprnewswire.com - March 7 at 3:45 AMWhy BiomX Stock Is Surging Todaymsn.com - March 6 at 4:14 PMWhy Is BiomX (PHGE) Stock Up 147% Today?investorplace.com - March 6 at 11:52 AMBiomX Announces Entry into Merger Agreement with Adaptive Phage Therapeutics and Concurrent $50 Million Financingglobenewswire.com - March 6 at 7:30 AMNanoViricides reports positive safety results for COVID drug candidatemsn.com - January 29 at 2:43 PMBiomX GAAP EPS of -$0.13 misses by $0.03msn.com - November 14 at 8:29 AMBiomX Reports Third Quarter 2023 Financial Results and Provides Business Updatefinance.yahoo.com - November 14 at 8:29 AMMustang Bio stock jumps 10% on FDA acceptance of new drug applicationmsn.com - October 26 at 12:27 PMHC Wainwright & Co. Reiterates BiomX (PHGE) Buy Recommendationmsn.com - August 9 at 3:54 PMBiomX GAAP EPS of -$0.12 beats by $0.02msn.com - August 9 at 10:53 AMPHGE - BiomX Inc.uk.finance.yahoo.com - July 19 at 10:54 PMNYSE American to Commence Delisting Proceedings with Respect to the Warrants of BiomX Inc. (PHGE.WS)finance.yahoo.com - June 2 at 8:03 PMBiomX to Present Part 1 Data from Phase 1b/2a Study Evaluating BX004 for the Treatment of Chronic Pseudomonas aeruginosa Pulmonary Infections in Patients with Cystic Fibrosis During Late-Breaking Science Session at the 46th European Cystic Fibrosis Conference (ECFC)finance.yahoo.com - May 31 at 6:35 AMHC Wainwright & Co. Maintains BiomX (PHGE) Buy Recommendationmsn.com - May 16 at 12:42 AMBiomX Announces the Appointments of Jason M. Marks and Michael E. Dambach to Board of Directorsfinance.yahoo.com - May 12 at 9:04 AMWhy Is BiomX (PHGE) Stock Up 10% Today?msn.com - May 12 at 9:04 AMBiomX to Host First Quarter 2023 Financial Results Conference Call and Webcast on May 15th, 2023finance.yahoo.com - May 8 at 8:21 AMBiomX Inc. (PHGE) Stock Historical Prices & Data - Yahoo Financeca.finance.yahoo.com - April 27 at 2:48 PMBiomX Inc. (PHGE-WT)ca.finance.yahoo.com - April 19 at 7:05 PMBiomX Inc. (AMEX:PHGE) Q4 2022 Earnings Call Transcriptfinance.yahoo.com - April 9 at 1:04 PMBiomX Stock (AMEX:PHGE), Dividendsbenzinga.com - April 1 at 12:01 AMBiomX Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updatefinance.yahoo.com - March 29 at 7:47 AMBiomX Announces Positive Results from Part 1 of the Phase 1b/2a Study Evaluating BX004 for Treatment of Chronic Pulmonary Infections in Patients with Cystic Fibrosisfinance.yahoo.com - February 22 at 7:31 AMBiomX Announces $7.5 Million Private Placementfinance.yahoo.com - February 22 at 7:31 AMWall Street Set to Open Higher Ahead of Manufacturing PMI, Fed Meetingmsn.com - November 1 at 1:48 PMBiomX: Top 10 Undervalued Healthcare Stocks on ASE (PHGE)theglobeandmail.com - October 5 at 3:38 PMPHGE_u Technical Analysisinvesting.com - September 1 at 8:24 PMBiomX Inc. (PHGE) CEO Jonathan Solomon on Q2 2022 Results - Earnings Call Transcriptseekingalpha.com - August 11 at 6:34 PMBiomX to Host Second Quarter 2022 Financial Results Conference Call and Webcast on August 10, 2022finance.yahoo.com - August 7 at 7:46 AMBiomX stock rises on team up with Boehringer inflammatory bowel disease biomarkersseekingalpha.com - June 28 at 7:55 AMBiomX Inc. (PHGE) CEO Jonathan Solomon on Q1 2022 Results - Earnings Call Transcriptseekingalpha.com - May 11 at 12:54 PMBiomX Reports First Quarter 2022 Financial Results and Provides Business Updatefinance.yahoo.com - May 11 at 7:54 AMBiomX to Host First Quarter 2022 Financial Results Conference Call and Webcast on May 11, 2022finance.yahoo.com - May 5 at 9:18 AMPHGE_u Historical Datainvesting.com - April 1 at 9:53 PMBiomX Presenting at Three Upcoming Investor Conferencesfinance.yahoo.com - February 24 at 10:30 AMDown 28.1% in 4 Weeks, Here's Why BiomX Inc. (PHGE) Looks Ripe for a Turnaroundfinance.yahoo.com - October 25 at 1:13 PMBiomX Inc. Shares Close in on 52-Week Low - Market Movernasdaq.com - September 29 at 9:57 PMBiomX Reports Second Quarter 2021 Financial Results and Provides Business Updatefinance.yahoo.com - August 16 at 6:50 AM Get BiomX News Delivered to You Automatically Sign up to receive the latest news and ratings for PHGE and its competitors with MarketBeat's FREE daily newsletter. Email Address Thousands of investors use this no cost solution | Do you? (Ad)In today’s volatile markets we are all looking for the edge. But imagine tapping into a world where every investment move has the potential to be ahead of the curve. Most investors have heard of the publication Insider Financial. For nearly a decade, they've unlocked doors to opportunities tucked away from the public eye, guiding over a million investors with well researched information before it hits the mainstream media. Simply tap here now to subscribe and start getting "Insider Financial Advantage" PHGE Media Mentions By Week PHGE Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PHGE News Sentiment▼0.040.44▲Average Medical News Sentiment PHGE News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PHGE Articles This Week▼40▲PHGE Articles Average Week Get BiomX News Delivered to You Automatically Sign up to receive the latest news and ratings for PHGE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Tevogen Bio News PHAXIAM Therapeutics News IntelGenx Technologies News BioRestorative Therapies News Pulmatrix News Calidi Biotherapeutics News LianBio News China Health Industries News Agape ATP News Alaunos Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEMKT:PHGE) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe #1 Crypto for 2024InvestorPlaceFed launches fourth dollar overhaulStansberry ResearchGreat Crypto BullWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BiomX Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
